Literature DB >> 1738576

Benzodiazepines and pain: effects of midazolam on the activities of nociceptive non-specific dorsal horn neurons in the rat spinal cord.

Nathalie Clavier1, Marie-Christine Lombard, Jean-Marie Besson.   

Abstract

The high density of GABA-benzodiazepine receptors in the superficial dorsal horn suggests a possible involvement of benzodiazepines (BZs) in the modulation of spinal pain processes. In this electrophysiological study we have examined the effects of midazolam (MZ), a water-soluble short-acting BZ, on the activities of 57 nociceptive non-specific dorsal horn cells, one in each animal. Recordings were performed at lumbar level in unanesthetized decerebrate spinal rats before and following intravenous injection of MZ (1, 2 or 5 mg/kg). The spontaneous activity was weakly and significantly but not dose dependently reduced by MZ. For the total neuronal population MZ induced no significant effect on C-fiber evoked responses, whatever the dose used. More precise analysis shows that for 45/55 neurons the responses were slightly depressed, but this effect was not dose dependent. In contrast, A delta-fiber evoked responses were markedly and dose dependently depressed. These effects of MZ were reversed by intravenous administration of the antagonist flumazenil (FZ). Despite the fact that MZ displays a very weak effect on responses due to C-fiber stimulation, the possible involvement of BZs in the modulation of nociceptive transmission at the level of the dorsal horn is discussed on the basis of clinical and experimental findings, taking into account the role of GABAergic mechanisms in sensory events.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1738576     DOI: 10.1016/0304-3959(92)90132-U

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  9 in total

1.  Analgesic efficacy and clinical acceptability of adjunct pre-emptive intravenous tramadol in midazolam sedation for third molar surgery.

Authors:  Lars Eriksson; Ake Tegelberg
Journal:  Oral Maxillofac Surg       Date:  2012-09-13

2.  Midazolam exacerbates morphine tolerance and morphine-induced hyperactive behaviors in young rats with burn injury.

Authors:  Li Song; Shuxing Wang; Yunxia Zuo; Lucy Chen; Jeevendra A Martyn; Jianren Mao
Journal:  Brain Res       Date:  2014-04-05       Impact factor: 3.252

3.  Low and high doses of midazolam differentially affect hypoalgesia in rats conditioned to a heat stressor.

Authors:  J A Harris; I S McGregor; R F Westbrook
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Midazolam administration reverses thermal hyperalgesia and prevents gamma-aminobutyric acid transporter loss in a rodent model of neuropathic pain.

Authors:  Andre Shih; Vjekoslav Miletic; Gordana Miletic; Lesley J Smith
Journal:  Anesth Analg       Date:  2008-04       Impact factor: 5.108

5.  [Intrathecal and epidural administration of non-opioid analgesics in acute and chronic pain treatment.].

Authors:  B Donner; M Tryba; M Zenz; M Strumpf
Journal:  Schmerz       Date:  1994-06       Impact factor: 1.107

6.  Benzodiazepines Suppress Neuromodulatory Effects of Pudendal Nerve Stimulation on Rat Bladder Nociception.

Authors:  Timothy J Ness; Jamie McNaught; Buffie Clodfelder-Miller; Dwight E Nelson; Xin Su
Journal:  Anesth Analg       Date:  2020-04       Impact factor: 5.108

7.  Interaction between midazolam and epibatidine in spinally mediated antinociception in rats.

Authors:  Tomoki Nishiyama
Journal:  J Anesth       Date:  2009-08-14       Impact factor: 2.078

8.  Effects of systemic bicuculline or morphine on formalin-evoked pain-related behaviour and c-Fos expression in trigeminal nuclei after formalin injection into the lip or tongue in rats.

Authors:  S Sugiyo; D Uehashi; F Satoh; T Abe; N Yonehara; M Kobayashi; Motohide Takemura
Journal:  Exp Brain Res       Date:  2009-05-22       Impact factor: 1.972

9.  Nociceptive transmission to rat primary somatosensory cortex--comparison of sedative and analgesic effects.

Authors:  Marcus Granmo; Tanja Jensen; Jens Schouenborg
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.